Get Live Data

SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Rtw Biotech Share Price
  4. Rtw Biotech Share Regulatory News
  5. Spectris

Pin to quick picksRtw Biotech Regulatory News (RTW)

Rtw Biotech Information

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Spectris

1 Dec 2025 18:00

RNS Number : 7232J
FTSE Russell
01 December 2025
 

 

 

Further to the FTSE Russell notice released on 25 November 2025 in relation to Spectris (UK): Constituent Deletion, please note the FTSE 250 Index replacement and associated changes.

 

All other details remain unchanged. Please see updated notice below:

Spectris (UK): Constituent Deletion - UpdateChanges in FTSE UK Index Series

01 December 2025

Subject to court sanctioning the scheme of arrangement for the cash offer for Spectris (UK, constituent) by Aurora Bidco Limited (non-constituent), please see details of affected indexes and effective dates below:

 

Spectris (UK, 0330860) will be deleted from the FTSE 250 Index.

 

RTW Biotech Opportunities (UK, BKTRRM2) will be added to the FTSE 250 Index and deleted from the FTSE SmallCap Index.

 

All changes effective from the open of Thursday 04 December 2025.

 

Full details of changes are available on the FTSE Russell website.

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+61 (0) 2 7228 5659

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1430

London

+44 (0) 20 7866 1810

New York

+1877 503 6437

Alternatively please visit our website at lseg.com/ftse-russell

Terms of Use | Copyright © 2025 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSTBBJTMTMMBIA
234567891011
Date   Source Headline
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:05 amRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNSNotice of Interim Report
17th Aug 20217:00 amRNSIssue of Equity
13th Aug 20214:05 pmRNSAnnouncement of Share Issuance
13th Aug 20217:00 amRNSNet Asset Value(s)
6th Aug 20217:00 amRNSCompletion of Transfer
5th Aug 20211:00 pmRNSTransfer to the Premium Segment of the LSE
2nd Aug 20217:01 amRNSPortfolio Company Update: Tenaya Therapeutics IPO
2nd Aug 20217:00 amRNSQuarterly Update
30th Jul 20213:50 pmRNSResult of Meeting
27th Jul 20217:05 amRNSNew Investment in Artios
15th Jul 20217:00 amRNSNet Asset Value(s)
14th Jul 20217:05 amRNSPortfolio Company Update
14th Jul 20217:00 amRNSPublication of Circular
1st Jul 20217:00 amRNSTotal Voting Rights
28th Jun 20217:00 amRNSPortfolio Company Update: GH Research IPO
25th Jun 20217:00 amRNSPortfolio Company Update: Monte Rosa IPO
22nd Jun 20214:49 pmRNSResult of AGM
18th Jun 20214:40 pmRNSSecond Price Monitoring Extn
18th Jun 20214:35 pmRNSPrice Monitoring Extension
16th Jun 20217:00 amRNSIssue of Equity
15th Jun 202112:05 pmRNSNew Investment in Umoja Biopharma
14th Jun 20212:32 pmRNSAnnouncement of Share Issuance
14th Jun 20217:00 amRNSNet Asset Value(s)
9th Jun 202112:05 pmRNSNew Investment in Alcyone Therapeutics
2nd Jun 20217:00 amRNSNotice of AGM
26th May 20211:05 pmRNSAdditional Investment in Portfolio Company
20th May 20218:05 amRNSNew Investment in Numab Therapeutics
14th May 20217:00 amRNSNet Asset Value(s)
29th Apr 20217:00 amRNSAnnual Financial Report
28th Apr 20217:00 amRNSQuarterly Update
19th Apr 20217:00 amRNSPortfolio Company Update: Biomea IPO
15th Apr 20217:00 amRNSNet Asset Value(s)
1st Apr 20217:05 amRNSTotal Voting Rights
1st Apr 20217:00 amRNSNotice of Annual Report
30th Mar 20211:00 pmRNSNew Investment in Pyxis Oncology
17th Mar 20217:00 amRNSIssue of Equity
15th Mar 20217:01 amRNSAnnouncement of Share Issuance
15th Mar 20217:00 amRNSPortfolio Company Update: Prometheus IPO
12th Mar 202112:30 pmRNSNew Investment in Monte Rosa Therapeutics
12th Mar 20217:00 amRNSNet Asset Value(s)
9th Mar 20211:45 pmRNSNew Investment in Ventyx Biosciences
9th Mar 202112:45 pmRNSNew Investment in Visus Therapeutics
1st Mar 20211:00 pmRNSNew Investment in Tenaya Therapeutics
1st Mar 20217:00 amRNSTotal Voting Rights
26th Feb 20211:15 pmRNSNew Investment in Artiva Biotherapeutics
18th Feb 20217:00 amRNSIssue of Equity
15th Feb 20214:10 pmRNSAnnouncement of Share Issuance
15th Feb 20217:00 amRNSNet Asset Value(s)
234567891011

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
RI48
Citi Fun 26
LSE
0.00%
JF78
Citi Fun 29
LSE
0.00%
DK32
Citi Fun 26
LSE
0.00%
0F9F
Minerva Insuran
LSE
0.00%
WRDK
Ubs Etf Wrdk
LSE
2.25%
Trending
IMM
Immupharma
LSE
5.42%
AVCT
Avacta Group
LSE
3.65%
SBTX
Skinbiotherap.
LSE
30.77%
SEE
Seeing Machines
LSE
-3.60%
PPP
Pennpetro Energy
LSE
0.00%